Skip to Content

Dimed SA Distribuidora de Medicamentos PNVL3

Morningstar Rating
BRL 11.20 −0.06 (0.53%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PNVL3 is trading at a 22% discount.
Price
BRL 11.29
Fair Value
BRL 52.91
Uncertainty
High
1-Star Price
BRL 37.35
5-Star Price
BRL 52.74
Economic Moat
Zrvl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PNVL3 is a good fit for your portfolio.

Trading Information

Previous Close Price
BRL 11.26
Day Range
BRL 11.1011.38
52-Week Range
BRL 9.6013.91
Bid/Ask
BRL 11.10 / BRL 11.40
Market Cap
BRL 1.67 Bil
Volume/Avg
367,100 / 365,876

Key Statistics

Price/Earnings (Normalized)
18.50
Price/Sales
0.41
Dividend Yield (Trailing)
2.26%
Dividend Yield (Forward)
2.26%
Total Yield
2.30%

Company Profile

Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Small Core
Total Number of Employees
10,284

Comparables

Valuation

Metric
PNVL3
PGMN3
HYPE3
Price/Earnings (Normalized)
18.5052.6111.58
Price/Book Value
1.550.561.72
Price/Sales
0.410.122.53
Price/Cash Flow
5.604.5812.84
Price/Earnings
PNVL3
PGMN3
HYPE3

Financial Strength

Metric
PNVL3
PGMN3
HYPE3
Quick Ratio
0.740.371.22
Current Ratio
1.621.391.74
Interest Coverage
1.840.482.28
Quick Ratio
PNVL3
PGMN3
HYPE3

Profitability

Metric
PNVL3
PGMN3
HYPE3
Return on Assets (Normalized)
3.43%−0.16%7.38%
Return on Equity (Normalized)
8.69%−0.58%15.83%
Return on Invested Capital (Normalized)
7.59%6.02%11.87%
Return on Assets
PNVL3
PGMN3
HYPE3
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoRmgtplypwXvz$713.8 Bil
JNJ
Johnson & JohnsonTwbmrbqPdn$348.1 Bil
MRK
Merck & Co IncJkvpzxwmfGmkfd$316.8 Bil
ABBV
AbbVie IncZybzkpmnsJpsmk$287.8 Bil
AZN
AstraZeneca PLC ADRLgycdmxqflVzr$209.9 Bil
RHHBY
Roche Holding AG ADRJjglhxthcyRhmmq$195.5 Bil
NVS
Novartis AG ADRMfjfznbwRlfg$190.5 Bil
PFE
Pfizer IncFfkynzpTvfc$146.7 Bil
AMGN
Amgen IncJkrzcsrrnWtmh$142.4 Bil
SNY
Sanofi SA ADRBtdlwkwJzhx$115.1 Bil

Sponsor Center